Detalhe da pesquisa
1.
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.
Rheumatology (Oxford)
; 61(5): 2088-2094, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34554243
2.
Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever.
Ann Rheum Dis
; 79(7): 960-968, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312770
3.
Recommendations for the management of autoinflammatory diseases.
Ann Rheum Dis
; 74(9): 1636-44, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109736
4.
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency.
Pediatr Rheumatol Online J
; 20(1): 56, 2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906690
5.
Management of Mevalonate Kinase Deficiency: A Pediatric Perspective.
Front Immunol
; 11: 1150, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32582214
6.
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
Pediatr Rheumatol Online J
; 16(1): 19, 2018 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562920
7.
Diagnostic Value of Urinary Mevalonic Acid Excretion in Patients with a Clinical Suspicion of Mevalonate Kinase Deficiency (MKD).
JIMD Rep
; 27: 33-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409462
8.
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.
Arthritis Rheumatol
; 68(11): 2795-2805, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213830